Table 2.
Role of tissue factor (TF) in venous and microvascular thrombosis models.
Thrombotic method | Vascular location | Animal species | Inhibitor/gene | TF dependent | Study description | Reference |
---|---|---|---|---|---|---|
Ligation | IVC | N-H Primate | PHA-796 | Yes | Thrombosis was inhibited in a dose-dependent manner | 66 |
Ligation | IVC | Rat | anti-TF Ab | Yes | Inhibition of TF abolished thrombosis from MVs collected from cardiac surgery patients | 67 |
Ligation | IVC | Mouse | Low TF gene | Yes | Low TF mice were protected from venous thrombosis | 9 |
Collagen-coated thread | Jugular Vein | Rabbit | anti-TF Ab | Yes | Inhibition of TF significantly downregulates fibrin accumulation | 68 |
Laser injury | Cremaster arterioles | Mouse | Low TF gene | Yes | Inhibition of thrombus formation displaying small platelet thrombi lacking TF or fibrin | 74 |
Laser injury | Cremaster arterioles | Mouse | Low TF gene | Yes | TF-bearing MVs derived from haematopoietic cells initiate thrombus formation | 75 |
Abbreviations: N-H: non-human; Ab: antibody; PHA-927: TF:FVII complex inhibitor